AI assistant
Sending…
Core Scientific, Inc./tx — Director's Dealing 2024
Dec 9, 2024
30992_dirs_2024-12-09_c463d98a-9fec-425f-8f1f-d480f4377e5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Core Scientific, Inc./tx (CORZ)
CIK: 0001839341
Period of Report: 2024-12-05
Reporting Person: DUCHENE TODD M (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-05 | Common Stock | X | 196977 | $0.01 | Acquired | 1858451 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-05 | Tranche 2 Warrants | $0.01 | X | 196977 | Disposed | 2029-01-23 | Common Stock (196977) | Direct |
Footnotes
F1: Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024.
More from Core Scientific, Inc./tx
Board/Management Information
2026
May 26
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
M&A Activity
2026
May 6
Regulatory Filings
2026
Apr 27
Capital/Financing Update
2026
Apr 21
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 31
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Capital/Financing Update
2026
Mar 23